Mark C. Gebhardt
Boston Children's Hospital(US)Clinical Orthopaedics and Related Research(US)
Publications by Year
Research Areas
Sarcoma Diagnosis and Treatment, Bone Tumor Diagnosis and Treatments, Management of metastatic bone disease, Orthopaedic implants and arthroplasty, Oral and Maxillofacial Pathology
Most-Cited Works
- → A System for the Functional Evaluation of Reconstructive Procedures After Surgical Treatment of Tumors of the Musculoskeletal System(1993)2,191 cited
- → Addition of Ifosfamide and Etoposide to Standard Chemotherapy for Ewing's Sarcoma and Primitive Neuroectodermal Tumor of Bone(2003)1,320 cited
- → p53 functions as a cell cycle control protein in osteosarcomas.(1990)766 cited
- → Osteosarcoma: The Addition of Muramyl Tripeptide to Chemotherapy Improves Overall Survival—A Report From the Children's Oncology Group(2008)738 cited
- → Osteosarcoma: A Randomized, Prospective Trial of the Addition of Ifosfamide and/or Muramyl Tripeptide to Cisplatin, Doxorubicin, and High-Dose Methotrexate(2005)712 cited
- → Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort(2019)